$263,223
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | ENTA Enanta Pharmaceuticals Inc | 2.9M | +0.0% | $41,788 | 15.9% |
| 2 | JAZZ Jazz Pharmaceuticals Plc | 167,816 | +0.0% | $40,439 | 15.4% |
| 3 | UTHR United Therapeutics Corp Del | 69,282 | −17.8% | $37,539 | 14.3% |
| 4 | BMRN Biomarin Pharmaceutical Inc | 524,786 | +0.0% | $30,028 | 11.4% |
| 5 | EXEL Exelixis Inc | 370,693 | −10.8% | $20,169 | 7.7% |
| 6 | ABT Abbott Laboratories | 200,000 | +3900.0% | $18,148 | 6.9% |
| 7 | SNY Sanofi Sa | 323,946 | +0.0% | $13,820 | 5.3% |
| 8 | SUPN Supernus Pharmaceuticals | 280,681 | +0.0% | $13,054 | 5.0% |
| 9 | RARE Ultragenyx Pharmaceutical In | 390,879 | +0.0% | $13,051 | 5.0% |
| 10 | VNDA Vanda Pharmaceuticals Inc | 1.2M | +0.0% | $7,224 | 2.7% |
| 11 | BNTX Biontech Se | 59,523 | +0.0% | $5,539 | 2.1% |
| 12 | GSK Gsk Plc | 96,729 | +0.0% | $5,071 | 1.9% |
| 13 | BIIB Biogen Inc | 20,000 | +0.0% | $4,321 | 1.6% |
| 14 | REGN Regeneron Pharmaceuticals | 6,000 | +50.0% | $3,741 | 1.4% |
| 15 | EMBC Embecta Corp | 1.1M | +54.4% | $3,701 | 1.4% |
| 16 | ARDX Ardelyx Inc | 534,523 | +6.9% | $2,726 | 1.0% |
| 17 | INMD Inmode Ltd | 120,942 | +0.0% | $1,768 | 0.7% |
| 18 | EOLS Evolus Inc | 157,985 | +0.0% | $1,096 | 0.4% |